The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study☆,☆☆,★
References (13)
- et al.
Stage III ovarian cancer: The role of maximal surgical cytoreduction
Gynecol. Oncol.
(1984) - et al.
Randomized trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma
Lancet
(1984) - et al.
Cancer Statistics, 1991
CA: A Journal for Clinicians
(1991) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
Nacl. Cancer Inst. Monogr.
(1975)- et al.
Primary cytoreductive surgery for epithelial ovarian cancer
Obstet. Gynecol.
(1983) - et al.
Prognostic factors in advanced ovarian cancer
J. Clin. Oncol.
(1986)
Cited by (514)
Epithelial ovarian cancer
2023, DiSaia and Creasman Clinical Gynecologic OncologyIs there a “low-risk” patient population in advanced epithelial ovarian cancer?: a critical analysis
2022, American Journal of Obstetrics and GynecologyOvarian Cancer
2022, Oncologic Imaging: A Multidisciplinary ApproachSecondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement
2021, Gynecologic Oncology
- ☆
Presented at the 23rd Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, March 15–18, 1992.
- ☆☆
The following are the participating institutions and the National Cancer Institute grants supporting this study: University of Alabama at Birmingham (CA 12484), The Oregon Health Sciences Center University (unfunded), Duke University Medical Center (CA 12534), Temple University Health Science Center Hospital (CA 27816), University of Rochester Medical Center (CA 12482), Walter Reed Army Medical Center (CA 23501), University of Minnesota Medical School (CA 23088), University of Southern California Medical Center at Los Angeles (CA 37535), University of Mississippi Medical Center (CA 13633), Colorado Foundation for Medical Care (CA 15975), University of California Medical Center at Los Angeles (CA 13630), The Milton S. Hershey School of Medicine of Pennsylvania State University (CA 16386), Georgetown University Hospital (CA 16938), University of North Carolina School of Medicine (CA 23073), University of Iowa Hospitals and Clinics (CA 19502), University of Texas Health Science Center at Dallas (CA 28160), Indiana University Medical Center (CA 21720), Bowman Gray School of Medicine of Wake Forest University (CA 21946), The Albany Medical College of Union University (unfunded), University of California Medical Center at Irvine (CA 23765), Tufts New England Medical Center (CA 37569), Illinois Cancer Council (CA 27806), University of Pittsburgh School of Medicine (unfunded), St. Louis University Medical Center (CA 35571), State University of New York Downstate Medical Center (CA 34477), Latter Day Saints Hospital (unfunded), Eastern Virginia Medical School (unfunded), Cleveland Clinic Foundation (unfunded), University of Utah Medical Center (CA 15469), University of Connecticut Medical Center (unfunded), University of Michigan Medical School (unfunded), University of Puerto Rico (unfunded), Jacksonville University Hospital (unfunded), and University of New Mexico and Cancer Treatment Center.
- ★
Reprint requests should be addressed to GOG Administrative Office, Suite 1945, 1234 Market Street, Philadelphia, PA 19107.